---
schema_version: "secwatch.filing_event.v1"
accession: "0001388658-22-000142"
form_type: "8-K"
ticker: "IRTC"
cik: "0001388658"
company_name: "iRhythm Holdings, Inc."
filed_at: "2022-09-21T23:59:59+00:00"
generated_at: "2026-06-23T08:15:15.893703+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# iRhythm sets $1B revenue target by 2027, reaffirms FY2022 guidance, targets 15% EBITDA margin

## Summary
- Reaffirms FY2022 guidance: revenue $415-420M (29-30% growth), gross margin 68-69%, adjusted EBITDA loss $12.5-17.5M.
- Sets 2027 goals: $1B+ revenue (~20% CAGR), gross margin ~73%, adjusted EBITDA margin ~15%.
- Plans international expansion to 7 countries; introduces Know Your Rhythm early detection program with Heartbeat Health.
- Targets $250M annual gross savings by 2027; expects continued innovation with Zio Monitor and ZEUS system.
- Core business driven by cardiology and PCP expansion; served 4M patients with 30% revenue CAGR over 5 years.

## SEC filing metadata
- accession: 0001388658-22-000142
- form_type: 8-K
- ticker: IRTC
- cik: 0001388658
- company_name: iRhythm Holdings, Inc.
- filed_at: 2022-09-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1388658/000138865822000142/0001388658-22-000142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1388658/000138865822000142/irtc-20220921.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001388658-22-000142
- JSON: https://secwatch.observer/filing/0001388658-22-000142.json
- Plain text: https://secwatch.observer/filing/0001388658-22-000142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.